Patents by Inventor Nicolas TREMAUDEUX

Nicolas TREMAUDEUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160318888
    Abstract: The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4?-acetoxy-2?-benzoyloxy-5?,20-epoxy-1?-hydroxy-7?, 10?-dimethoxy-9-oxo-11-taxen-13?-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
    Type: Application
    Filed: April 7, 2016
    Publication date: November 3, 2016
    Inventors: Eric DIDIER, Nicolas TREMAUDEUX, Lionel ZASKE
  • Patent number: 9309210
    Abstract: The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4?-acetoxy-2?-benzoyloxy-5?,20-epoxy-1?-hydroxy-7?,10?-dimethoxy-9-oxo-11-taxen-13?-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: April 12, 2016
    Assignee: AVENTIS PHARMA S.A.
    Inventors: Eric Didier, Nicolas Tremaudeux, Lionel Zaske
  • Publication number: 20140343133
    Abstract: The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4?-acetoxy-2?-benzoyloxy-5?,20-epoxy-1?-hydroxy-7?,10?-dimethoxy-9-oxo-11-taxen-13?-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
    Type: Application
    Filed: June 11, 2014
    Publication date: November 20, 2014
    Inventors: Eric DIDIER, Nicolas TREMAUDEUX, Lionel ZASKE
  • Publication number: 20120302759
    Abstract: The invention relates to a method for preparing a combretastatin derivative (I) or (II), said method including the following steps: triaryl(3,4,5-trimethoxybenzyl)phosphonium halide P3 (III), wherein Ar denotes an aryl group selected from among phenyl or thienyl, is reacted with P2 having formula (IV) or P?2 having formula (V) so as to respectively obtain the compound P4 or P?4, which have formulas (VI) and (VII), respectively; then, during a step for deprotection in the presence of an acid and/or a base, the compound having P4 or P?4 leads, after an optional purification step, to the compound having formula (I) or (II).
    Type: Application
    Filed: June 4, 2012
    Publication date: November 29, 2012
    Applicant: C/O SANOFI
    Inventors: Pascal BESSE, Eric DIDIER, Nicolas TREMAUDEUX